Adjuvant Therapy with Methylene Blue in the Treatment of Right Ventricular Failure after Pulmonary Embolectomy

Heart Lung and Circulation

Volumn 20, Issue 4, 2011, Pages 234-236

  Raikhelkar, Jayashree K ^a   Milla, Federico ^a   Darrow, Bruce ^a   Scurlock, Corey ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Methylene blue; Pulmonary embolism; Right ventricular dysfunction

Indexed keywords

ADRENALIN; DOBUTAMINE; LACTIC ACID; METHYLENE BLUE; NITRIC OXIDE; NORADRENALIN; VASOPRESSIN;

ACIDOSIS; ACUTE DISEASE; ADJUVANT THERAPY; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CENTRAL VENOUS PRESSURE; CORONARY ARTERY BLOOD FLOW; CYANOSIS; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFECT; EMBOLECTOMY; HEART AFTERLOAD; HEART ATRIUM THROMBOSIS; HEART LEFT VENTRICLE FILLING; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HYPOTENSION; KIDNEY FAILURE; LOADING DRUG DOSE; LUNG EMBOLISM; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; RENAL REPLACEMENT THERAPY; SURGICAL APPROACH; TRACHEOSTOMY; TRANSTHORACIC ECHOCARDIOGRAPHY; URINE VOLUME; VASOPLEGIA; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; CHEMOTHERAPY, ADJUVANT; EMBOLECTOMY; ENZYME INHIBITORS; HUMANS; MALE; METHYLENE BLUE; PULMONARY EMBOLISM; VASOPLEGIA; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 79952902069     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2010.08.018     Document Type: Article

References (16)

1. Leyh R.G., Kofidis T., Struber M., Fischer S., Knobloch K., Wachsmann B., et al. Methylene blue: the drug of choice for catecholamine refractory vasoplegia after cardiopulmonary bypass?. J Thorac Cardiovasc Surg 2003, 125:1426-1431.
2. Friedrich M., Brauer A., Tirilomis T., Lotfi S., Mielck F., Busch T. Methylene blue administration in severe systemic inflammation response syndrome (SIRS) after thoracic surgery. Ann Thorac Cardiovasc Surg 2002, 8(5):306-310.
3. Kirov M.Y., Evgenov O.V., Evgenov N.V., Sovershaev M.A., Sveinbjφrnsson B., Nedashkovsky E.V. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 2001, 29(10):1860-1867.
4. Stein M., Levy S.E. Reflex and humoral responses to pulmonary embolism. Prog Cardiovasc Dis 1974, 17:167-174.
5. Malik A.B. Pulmonary microembolism. Phystol Rev 1983, 63:1114-1207.
6. Taylor R.R., Covell J.W., Sonnenblick E.H., Ross J. Dependence of ventricular distensibility on filling of the opposite ventricle. Am J Physiol 1967, 213:711-718.
7. Lualdi J.C., Goldhaber S.Z. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995, 130:1276-1282.
8. Preiser J.C., Lejeun P., Roman A., Carlier E., De Backer D., Leeman M., et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med 1995, 23:259-264.
9. Donati A., Conti G., Loggi S., Munch C., Coltrinari R., Pelaia P., et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?. Crit Care Med 2002, 30:2271-2277.
10. Ozal E., Kuralay E., Yildirim V., Kilic S., Bolcal C., Kucukarslan N., et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 2005, 79:1615-1619.
11. Levin R.L., Degrange M.A., Bruno G.F., Del Mazo C.D., Taborda D.J., Griotti J.J., et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004, 77:496-499.
12. Gachot B., Bedos J.P., Veber B., Wolff M., Regnier B. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med 1995, 21:1027-1031.
13. Kofidis T., Struber M., Wilhelmi M., Anssar M., Simon A., Harringer W., et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg 2001, 122:823-824.
14. Sitbon O., Brenot F., Denjean A., Bergeron A., Parent F., Azarian R., et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995, 151:384-389.
15. Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., Zapol W.M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993, 328:399-405.
16. Capellier G., Jacques T., Balvay P., Blasco G., Belle E., Barale F. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med 1997, 23:1089-1092.